Bone Marrow Micrometastasis in Breast Cancer
Author Information
Author(s): Vincent-Salomon A, Bidard F C, Pierga J Y
Primary Institution: Institut Curie, Paris, France
Hypothesis
The presence of disseminated tumour cells in bone marrow is an independent prognostic factor for breast cancer outcomes.
Conclusion
Detection of disseminated tumour cells in bone marrow is a significant prognostic factor for poor survival in breast cancer patients.
Supporting Evidence
- Detection of disseminated tumour cells in bone marrow is associated with poor outcomes in breast cancer.
- Standardized methodologies for detecting disseminated tumour cells are necessary for accurate prognostic assessment.
- The presence of micrometastases at diagnosis was detected in 30.6% of patients in a pooled analysis.
Takeaway
Doctors can find tiny cancer cells in the bone marrow of breast cancer patients, which can help predict how well the patient will do in the future.
Methodology
The review summarizes various methodologies for detecting disseminated tumour cells in bone marrow, including immunocytochemistry and molecular biology techniques.
Limitations
Bone marrow aspiration is not a routine procedure and may not be convenient for patients.
Participant Demographics
Patients with stage I to III breast cancer.
Statistical Information
P-Value
p<0.001
Statistical Significance
p<0.001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website